Sigyn Therapeutics, Inc. (SIGY) stock
SIGYOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2025, quý kết thúc ngày Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 0/30
$0.03+0.00 (0.00%)
Close on Oct 19, 2026Market cap $48.16KP/E –Yield –
Sigyn Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Sigyn Therapeutics's total assets was $135.57K at Sep 30, 2025. For fiscal 2024 it was $213.72K, down 33.6% from the year before. The highest annual figure on record is $2.07M in fiscal 2017.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $213.72K | -33.6% |
| FY2023 | Dec 31, 2023 | $321.81K | -3.3% |
| FY2022 | Dec 31, 2022 | $332.88K | -53.1% |
| FY2021 | Dec 31, 2021 | $710.26K | +2.3% |
| FY2020 | Dec 31, 2020 | $694.08K | – |
| FY2019 | Dec 31, 2019 | $0 | -100.0% |
| FY2018 | Dec 31, 2018 | $862.05K | -58.4% |
| FY2017 | Dec 31, 2017 | $2.07M | +45.1% |
| FY2015 | Dec 31, 2015 | $1.43M | +153.8% |
| FY2014 | Dec 31, 2014 | $562.27K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2025 | Sep 30, 2025 | $135.57K | -68.3% |
| Q2 FY2025 | Jun 30, 2025 | $51.76K | -83.8% |
| Q1 FY2025 | Mar 31, 2025 | $244.31K | -24.4% |
| Q4 FY2024 | Dec 31, 2024 | $213.72K | -33.6% |
| Q3 FY2024 | Sep 30, 2024 | $427.44K | +10.4% |
| Q2 FY2024 | Jun 30, 2024 | $320.17K | -11.5% |
| Q1 FY2024 | Mar 31, 2024 | $323.30K | -51.0% |
| Q4 FY2023 | Dec 31, 2023 | $321.81K | -3.3% |
| Q3 FY2023 | Sep 30, 2023 | $387.22K | +6.9% |
| Q2 FY2023 | Jun 30, 2023 | $361.82K | -8.6% |
| Q1 FY2023 | Mar 31, 2023 | $660.45K | +47.6% |
| Q4 FY2022 | Dec 31, 2022 | $332.88K | -53.1% |
| Q3 FY2022 | Sep 30, 2022 | $362.27K | -74.9% |
| Q2 FY2022 | Jun 30, 2022 | $395.91K | -80.1% |
| Q1 FY2022 | Mar 31, 2022 | $447.41K | -26.5% |
| Q4 FY2021 | Dec 31, 2021 | $710.26K | +2.3% |
| Q3 FY2021 | Sep 30, 2021 | $1.44M | +136.1% |
| Q2 FY2021 | Jun 30, 2021 | $1.99M | +220.0% |
| Q1 FY2021 | Mar 31, 2021 | $608.96K | -3.9% |
| Q4 FY2020 | Dec 31, 2020 | $694.08K | – |
| Q3 FY2020 | Sep 30, 2020 | $610.18K | -20.0% |
| Q2 FY2020 | Jun 30, 2020 | $622.69K | -22.1% |
| Q1 FY2020 | Mar 31, 2020 | $633.58K | -23.3% |
| Q4 FY2019 | Dec 31, 2019 | $0 | -100.0% |
| Q3 FY2019 | Sep 30, 2019 | $763.15K | -59.1% |
| Q2 FY2019 | Jun 30, 2019 | $798.84K | -58.7% |
| Q1 FY2019 | Mar 31, 2019 | $826.00K | -59.6% |
| Q4 FY2018 | Dec 31, 2018 | $862.05K | -58.4% |
| Q3 FY2018 | Sep 30, 2018 | $1.87M | +76.4% |
| Q2 FY2018 | Jun 30, 2018 | $1.93M | +66.9% |
| Q1 FY2018 | Mar 31, 2018 | $2.05M | +58.0% |
| Q4 FY2017 | Dec 31, 2017 | $2.07M | +45.1% |
| Q3 FY2016 | Sep 30, 2016 | $1.06M | – |
| Q2 FY2016 | Jun 30, 2016 | $1.16M | – |
| Q1 FY2016 | Mar 31, 2016 | $1.29M | – |
| Q4 FY2015 | Dec 31, 2015 | $1.43M | – |
See a number that looks wrong?